Karuna Therapeutics (KRTX) Market Cap

Price: $329.83
Market Cap: $12.60B
Avg Volume: 971.83K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.149
52W Range: $158.375-329.99
Website: Karuna Therapeutics

Market Cap Overview

Market Cap

$12.60B

Share Price

$329.83

Shares Outstanding

38.20M


What is Karuna Therapeutics's Market Cap?

Karuna Therapeutics's current Market Cap as of today is $12.60B.

Understanding Market Capitalization

Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.

  • It provides a straightforward method of gauging a company's size.
  • Market Cap can be used to compare companies within the same industry.

How is Market Cap calculated?

Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:

Market Cap = Current Share Price × Total Shares Outstanding

In the case of Karuna Therapeutics, the market cap is calculated as $329.83 x 38.20M shares = $12.60B.

As a Large Cap company, Karuna Therapeutics is considered a large, well-established company.

Karuna Therapeutics Historical Market Cap

$15.00B$15.00B$12.00B$12.00B$9.00B$9.00B$6.00B$6.00B$3.00B$3.00B$0.00$0.00Market CapJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Download SVG
Download PNG
Download CSV

Karuna Therapeutics Market Cap vs Enterprise Value

Understanding Market Cap vs. Enterprise Value

While market cap represents the equity value of Karuna Therapeutics, enterprise value provides a more complete picture of the company's total value by including debt and cash:

Market Cap
Enterprise Value
$12.00B$12.00B$9.00B$9.00B$6.00B$6.00B$3.00B$3.00B$0.00$0.00-$3.00B-$3.00BValueJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Download SVG
Download PNG
Download CSV

Enterprise Value = Market Cap + Total Debt - Cash and Equivalents

Karuna Therapeutics's enterprise value as of December 31, 2023 (Q4 2023) is calculated as:

  • Market Cap: $12.60B
  • Total Debt: $16.69M
  • Cash and Equivalents: $185.82M
  • Enterprise Value: $11.79B

The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A lower enterprise value indicates a strong net cash position.

Karuna Therapeutics Annual Market Cap History

Year Market Cap Change
2025 $12.60B 7.71%
2023 $11.70B 88.22%
2022 $6.22B 62.82%
2021 $3.82B 42.08%
2020 $2.69B 198.21%
2019 $900.93M 314.17%
2018 $217.52M 46.41%
2017 $148.57M N/A

Frequently Asked Questions

Karuna Therapeutics's current market capitalization is $12.60B. This makes it a Large Cap company, calculated by multiplying its current stock price of $329.83 by 38.20M outstanding shares.

Karuna Therapeutics's enterprise value is $11.79B. This is calculated by adding total debt ($16.69M) to market cap and subtracting cash and equivalents ($185.82M). Enterprise value provides a more complete picture of the company's total value by considering both its debt and cash positions.

Karuna Therapeutics has 38.20M shares outstanding. This number represents the total number of shares currently held by all shareholders, including company insiders, institutional investors, and the public.

Karuna Therapeutics is classified as a Large Cap company. Large-cap companies are well-established companies with market caps between $10 billion and $200 billion.

Karuna Therapeutics's market cap is calculated by multiplying its current stock price ($329.83) by its total number of outstanding shares (38.20M). This calculation represents the total market value of all the company's outstanding shares at the current market price.

Related Metrics

Explore detailed financial metrics and analysis for KRTX.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio